BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32255255)

  • 1. Cell type-specific transcriptomics of esophageal adenocarcinoma as a scalable alternative for single cell transcriptomics.
    Krämer M; Plum PS; Velazquez Camacho O; Folz-Donahue K; Thelen M; Garcia-Marquez I; Wölwer C; Büsker S; Wittig J; Franitza M; Altmüller J; Löser H; Schlößer H; Büttner R; Schröder W; Bruns CJ; Alakus H; Quaas A; Chon SH; Hillmer AM
    Mol Oncol; 2020 Jun; 14(6):1170-1184. PubMed ID: 32255255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell RNA sequencing reveals diverse intratumoral heterogeneities and gene signatures of two types of esophageal cancers.
    Wu H; Yu J; Li Y; Hou Q; Zhou R; Zhang N; Jing Z; Jiang M; Li Z; Hua Y; Brunicardi FC; Wu S
    Cancer Lett; 2018 Dec; 438():133-143. PubMed ID: 30223068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
    Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
    Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
    Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
    World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific gene expression profiles are associated with a pathologic complete response to neoadjuvant therapy in esophageal adenocarcinoma.
    McLaren PJ; Barnes AP; Terrell WZ; Vaccaro GM; Wiedrick J; Hunter JG; Dolan JP
    Am J Surg; 2017 May; 213(5):915-920. PubMed ID: 28385379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns.
    Guo X; Tang Y; Zhu W
    BMC Genomics; 2018 Oct; 19(1):769. PubMed ID: 30355311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic marker signature for esophageal cancer from transcriptome analysis.
    Warnecke-Eberz U; Metzger R; Hölscher AH; Drebber U; Bollschweiler E
    Tumour Biol; 2016 May; 37(5):6349-58. PubMed ID: 26631031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus.
    Hezova R; Kovarikova A; Srovnal J; Zemanova M; Harustiak T; Ehrmann J; Hajduch M; Svoboda M; Sachlova M; Slaby O
    Diagn Pathol; 2015 Apr; 10():42. PubMed ID: 25928282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of esophageal cancer: comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma.
    Greenawalt DM; Duong C; Smyth GK; Ciavarella ML; Thompson NJ; Tiang T; Murray WK; Thomas RJ; Phillips WA
    Int J Cancer; 2007 May; 120(9):1914-21. PubMed ID: 17236199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
    Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
    Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers.
    Kashyap MK; Marimuthu A; Kishore CJ; Peri S; Keerthikumar S; Prasad TS; Mahmood R; Rao S; Ranganathan P; Sanjeeviah RC; Vijayakumar M; Kumar KV; Montgomery EA; Kumar RV; Pandey A
    Cancer Biol Ther; 2009 Jan; 8(1):36-46. PubMed ID: 18981721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
    Bonde P; Sui G; Dhara S; Wang J; Broor A; Kim IF; Wiley JE; Marti G; Duncan M; Jaffee E; Montgomery E; Maitra A; Harmon JW
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):763-9. PubMed ID: 17320581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the immune infiltrate and patient outcomes in esophageal cancer.
    Conroy MJ; Kennedy SA; Doyle SL; Hayes B; Kavanagh M; van der Stok EP; O'Sullivan K; Cathcart MC; Reynolds JV; Lysaght J
    Carcinogenesis; 2021 Apr; 42(3):395-404. PubMed ID: 32940666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblasts derived from oesophageal adenocarcinoma differ in DNA methylation profile from normal oesophageal fibroblasts.
    Smith E; Palethorpe HM; Hayden AL; Young JP; Underwood TJ; Drew PA
    Sci Rep; 2017 Jun; 7(1):3368. PubMed ID: 28611465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Integrative "Omics" Approach, for Identification of Bona Fides PLK1 Associated Biomarker in Esophageal Adenocarcinoma.
    Bibi N; Rashid S; Nicholson J; Malloy M; O'Neill R; Blake D; Hupp T
    Curr Cancer Drug Targets; 2019; 19(9):742-755. PubMed ID: 30747067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic Microenvironment of Lung Adenocarcinoma.
    Bossé Y; Sazonova O; Gaudreault N; Bastien N; Conti M; Pagé S; Trahan S; Couture C; Joubert P
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):389-396. PubMed ID: 27956437
    [No Abstract]   [Full Text] [Related]  

  • 17. The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell types.
    Sørensen BS; Knudsen A; Wittrup CF; Nielsen S; Aggerholm-Pedersen N; Busk M; Horsman M; Høyer M; Bouchelouche PN; Overgaard J; Alsner J
    Radiother Oncol; 2015 Sep; 116(3):346-51. PubMed ID: 26169282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation Sequencing.
    Chiam K; Mayne GC; Watson DI; Woodman RJ; Bright TF; Michael MZ; Karapetis CS; Irvine T; Phillips WA; Hummel R; Wang T; Pimlott LK; Marri S; Astill DS; Ruszkiewicz AR; Thompson SK; Hussey DJ
    Ann Surg Oncol; 2018 Sep; 25(9):2731-2738. PubMed ID: 29987600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus.
    Hezova R; Kovarikova A; Srovnal J; Zemanova M; Harustiak T; Ehrmann J; Hajduch M; Sachlova M; Svoboda M; Slaby O
    Tumour Biol; 2016 Jun; 37(6):8007-18. PubMed ID: 26711784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weighted gene co-expression network analysis of gene modules for the prognosis of esophageal cancer.
    Zhang C; Sun Q
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):319-325. PubMed ID: 28585144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.